Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule.
- 1 March 1990
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 87 (6) , 2137-2141
- https://doi.org/10.1073/pnas.87.6.2137
Abstract
The CD8 molecule on class I-reactive cytotoxic T lymphocytes (CTLs) is believed to function as a coreceptor along with the .alpha..beta. T-cell receptor. Whereas the .alpha..beta. T-cell receptor recognizes polymorphic residues in the .alpha.1/.alpha.2 domains of the class I molecule, the CD8 molecule is believed to recognize monomorphic class I residues. Our previous experiments suggested that residue 227 in the .alpha.3 domain of major histocompatibility complex class I molecules contributes to the determinant recognized by CD8. By using a panel of site-directed mutants of H-2Dd, this observation has been extended herein. Our findings indicate that for recognition by CD8-dependent CTLs, residue 227 must be either glutamic acid or aspartic acid and cannot be either basic or uncharged. However, the recognition by CD8-independent CTLs is unaffected by any of the substitutions at position 227 of H-2Dd. Similarly, alterations of other charged residues at positions 222, 223, and 229 have an analogous effect to substitution at residue 227, whereas substitutions at residues 192 and 232 do not affect the reactivity of CD8-dependent or CD8-independent CTLs. In addition, mutant H-2Dd molecules that are not recognized by CD8-dependent CTLs are unable to stimulate a primary CTL response, yet they can stimulate a secondary CD8-independent H-2Dd-specific CTL response. These findings suggest that CD8 recognition is obligatory for the priming of class I-dependent CTL responses. Since endogenous class I molecules were expressed by all of the transfected cell lines, these findings provide direct genetic evidence that CD8 and the .alpha..beta. T-cell receptor must interact with the same class I molecule.This publication has 32 references indexed in Scilit:
- Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8Nature, 1989
- Direct evidence for binding of CD8 to HLA class I antigens.The Journal of Experimental Medicine, 1989
- Cell-cell adhesion mediated by CD8 and MHC class I moleculesNature, 1988
- Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatmentNature, 1988
- Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cellsNature, 1988
- The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses.The Journal of Experimental Medicine, 1988
- A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL.The Journal of Experimental Medicine, 1987
- Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genesCell, 1987
- MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENSTransplantation, 1982
- Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.The Journal of Experimental Medicine, 1979